CANADIAN AIR TRANSPORT SECURITY AUTHORITY AIRPORT BODY SCREENING RESULTS

Results are probably similar in USA airports.

 

FULL BODY SCANS AT CANADIAN AIRPORTS:

CATSA disclosed the following Airport Screening Results

December 2012 Statistics On Airport Full Body Screening From CATSA :
Terrorists Discovered	0
Transvestites	133
Hernias	1,485
Hemorrhoid Cases	3,172
Enlarged Prostates	8,249
Breast Implants	59,350
Natural Blondes	3

It was also discovered that 308 politicians had no balls.

Thought you'd like to know.

Generic Drugs Are Actually Not the Same as Name-Brands, Thanks to FDA Malfeasance

ProPublica / by Charles Seife, Bob Garver

The FDA failed to address compromised lab tests suggesting generic drugs are more similar to name-brands than they really are.

April 24, 2013  |  

 

 

 

 

Andrew Richards remembers that he had just sat down in front of the TV when the lightning bolt struck. “It was almost like it went through my ear because I could hear it. It was kind of like, ‘fwomp,’ right through my head,” he says.

Stunned and disoriented, Richards tried to get up, he says, but spasms rumbled through his torso and his back; his muscles kept clenching and relaxing. He doesn’t recall falling. “It was almost like a little piece of time was missing, almost like a record skipped ahead a little bit,” he says, “like I was sitting on my couch and time had moved forward and I was on the floor.”

The next thing Richards remembers was calling out to his wife, who scooped him up and drove him to the emergency room. He would soon discover that the lightning bolt that struck him down was an electrical storm taking place entirely in his brain: a seizure. Less than a year later he was in court, contending that his seizure — and the spasms that he says still plague him — were caused by a faulty generic medication.

Generic medications are generally safe and effective, because the Food and Drug Administration mandates tests to show that they are equivalent to the name-brand originals. But in 2011, the Food and Drug Administration determined that a major laboratory had committed such “egregious” research violations that years’ worth of its tests — many comparing generics to name-brand drugs — were potentially worthless. The FDA has required drug manufacturers to redo many of the tests from that lab, owned by the now-defunct Cetero Research. But a  ProPublica investigation shows that the agency took little action to prevent consumers from taking medicines the FDA no longer knew for sure were safe or effective.

Read full text here

Finger nail creatinine and its role in confirming chronicity of renal failure

SJ Jessy¹, RK Visweswaran², B Sulekha^3
1 Department of Biochemistry, Government Medical College, Trivandrum, Kerala, India
² Department of Nephrology, Ananthapuri Hospitals and Research Institute, Trivandrum, Kerala, India
³ Department of Biochemistry, SUT Academy of Medical Sciences, Trivandrum, Kerala, India

Indian Journal of Nephrology http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2013;volume=23;issue=2;spage=114;epage=118;aulast=Jessy

Abstract

It is often difficult to differentiate acute renal failure (ARF) from chronic renal failure (CRF) when the patient presents with advanced uremia for the first time. Assessments of kidney size, history of nocturia, and pallor are used as indirect indicators of CRF. Some investigators have proposed an estimation of finger nail creatinine concentrations to differentiate between ARF and CRF, as patients with CRF have higher nail creatinine concentrations. Measurement of creatinine in the nail can be performed easily in a biochemistry laboratory. The nail clippings are cleaned, dried, pulverized and creatinine extracted from the powdered nail to be assessed biochemically. By standardizing the methods, the biochemistry laboratory can provide the results within 48 hours. In this study, we analyzed the nail clippings of 49 normal subjects, 50 cases of known acute kidney injury (AKI), and 50 cases of known CRF on follow-up at the Nephrology Clinic, Medical College, Trivandrum between December 1999 to November 2000. Forty-nine normal individuals were selected from healthy bystanders of respective patients. On study, it was revealed that patients with ARF had a mean fingernail creatinine level of 30.9 mg/100 g of nail as against 30.1 mg/100 g of nail in normal controls. There was no difference between the controls and ARF patients.Patients with known CRF had a mean fingernail creatinine level of 69.2 mg/100 g. There was a significant increase in the level of nail creatinine in patients with known CRF versus ARF patients and normal controls. The measurement of nail creatinine is useful, easy and can be standardized and performed in a biochemistry laboratory. This simple investigation can help in solving the question of ARF versus CRF in a given case. From this study, it is concluded that the result of creatinine concentrations of nail clippings can indicate chronicity of renal failure.

Read full text here

Hospital Charts..Have a good laugh!!!!     ACTUAL SENTENCES FOUND ON PATIENTS' HOSPITAL CHARTS: 1)  She has no rigors or shaking chills, but her husband states she was hot in bed last night. 2)  Patient has chest pain if she lies on her left side for over a year.   3)  On the second day the knee was better, and on the third day it disappeared. 4)  The patient is tearful and crying constantly. She also appears to  be depressed. 5)  The patient has been depressed since she began seeing me in 1993. 6)  Discharge status: Alive but without my permission. 7)  Healthy appearing decrepit 69 year old male, mentally alert but forgetful.   8)  The patient refused autopsy. 9)  The patient has no previous history of suicides. 10) Patient has left white blood cells at another hospital.   11) Patient's medical history has been remarkably insignificant with only a 40 pound weight gain in the past 3 days. 12) Patient had waffles for breakfast and anorexia for lunch.   13) Between you and me, we ought to be able to get this lady pregnant. 14) Since she can't get pregnant with her husband, I thought you might want to work her up. 15) She is numb from her toes down. 16) While in ER, she was examined, X-rated and sent home. 17) The skin was moist and dry. 18) Occasional, constant, infrequent headaches.   19) Patient was alert and unresponsive. 20) Rectal examination revealed a normal sized thyroid. 21) She stated that she had been constipated for most of her life,  until she got a divorce. 22) I saw your patient today, who is still under our car for physical therapy. 23) Both breasts are equal and reactive to light and accommodation.   24) Examination of genitalia reveals that he is circus sized. 25) The lab test indicated abnormal lover function. 26) The patient was to have a bowel resection. However, he took a job as a stockbroker instead. 27) Skin: somewhat pale but present. 28) The pelvic exam will be done later on the floor. 29) Patient was seen in consultation by Dr Blank, who felt we should sit on the abdomen and I agree. 30) Large brown stool ambulating in the hall. 31) Patient has two teenage children, but no other abnormalities.

 

Al Fatihah

to the families of our fallen heroes

in Sabah

May God blessed their souls

and may they rest in peace.

Wishing all

Chinese Brothers and Sisters

A Happy and Prosperous

Chinese New Year!

"Kong Xi Fatt Choy"

Warmest Regards and Best Wishes

Malaysian KidneySPA

Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.

Turek NF, Ricardo AC, Lash JP.

Source

Sleep, Metabolism and Health Center, Department of Medicine, University of Chicago, Chicago, IL 60612-7315, USA.

Am J Kidney Dis. 2012 Nov;60(5):823-33. doi: 10.1053/j.ajkd.2012.04.027. Epub 2012 Jun 21.

Submitted by: Rusminah Sudin

Abstract

Despite the high prevalence and enormous public health implications of chronic kidney disease (CKD), the factors responsible for its development and progression are incompletely understood. To date, only a few studies have attempted to objectively characterize sleep in patients with CKD prior to kidney failure, but emerging evidence suggests a high prevalence of sleep disorders, particularly obstructive sleep apnea. Laboratory and epidemiologic studies have shown that insufficient sleep and poor sleep quality promote the development and exacerbate the severity of 3 important risk factors for CKD, namely hypertension, type 2 diabetes, and obesity. In addition, sleep disturbances might have a direct effect on CKD through chronobiological alterations in the renin-angiotensin-aldosterone system and sympathetic nervous system activation. The negative impact of sleep disorders on vascular compliance and endothelial function also may have a deleterious effect on CKD. Sleep disturbances therefore may represent a novel risk factor for the development and progression of CKD. Optimizing sleep duration and quality and treating sleep disorders may reduce the severity and delay the progression of CKD.